Qiagen announced key updates to its sample technologies solutions for non-invasive liquid biopsy applications for use in research and clinical applications such as oncology, prenatal care and organ transplantation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Neogen appoints Bernard to the board of directors
- Qiagen gets European IVDR certification
- Qiagen, Bode team to advance GEDmatch PRO forensic genealogy database
- Qiagen launches 100 new assays for its digital PCR to study cancer
- Qiagen and Bio-Manguinhos/Fiocruz collaborate to enhance malaria screening